Register for your FREE account now and join thousands of oncology professionals who stay informed about patient care issues, practical oncology-care management techniques, and drug administration and dosage information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Patient Information

This page provides articles and links to information about cancer and its treatments.
10 questions to ask at your next exam provides information on improving communication with your health care providers.

The American Society of Clinical Oncology's Cancer.Net offers information about ovarian cancer, coping, survivorship, advocacy and policy, publications, multimedia, and more.

Is a clinical trial right for me? offers an overview of factors to consider before deciding to enroll in a clinical trial.

For links to resources about treatment options for recurrent ovarian cancer, click here.

Gemzar explains the diagnosis, staging, side effects, and more about various types of cancer. It also provides facts about Gemzar and other treatment options.

What you should know about chemotherapy drugs provides information on factors you should consider when selecting a treatment for ovarian cancer.

ONA Newsletters
 
We've updated our newsletter offerings. Click here to update your subscriptions:
  • Issue Preview features articles in our current print edition
  • Editor's choice highlights articles and features of special interest
  • ONA Online includes Latest CE, Communications, Stat Consult, Survivorship, Palliative Care, Ask A Pharmacist, Reflections, and New on the Web
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

BI-RADS and breast MRI useful in predicting malignancy

Delicia Honen Yard May 30, 2012

The Breast Imaging Reporting and Data System (BI-RADS) terminology is useful in predicting malignancy in breast lesions detected with MRI.
 

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Lenalidomide use after autologous stem-cell transplant significantly improved progression-free and overall survival in patients with myeloma.
 

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.
 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions